KR20160146760A - 이미다졸디펩티드를 포함하는 제제 - Google Patents

이미다졸디펩티드를 포함하는 제제 Download PDF

Info

Publication number
KR20160146760A
KR20160146760A KR1020167030159A KR20167030159A KR20160146760A KR 20160146760 A KR20160146760 A KR 20160146760A KR 1020167030159 A KR1020167030159 A KR 1020167030159A KR 20167030159 A KR20167030159 A KR 20167030159A KR 20160146760 A KR20160146760 A KR 20160146760A
Authority
KR
South Korea
Prior art keywords
group
genes
aging
metabolites
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020167030159A
Other languages
English (en)
Korean (ko)
Inventor
다츠히로 히사츠네
마모루 도츠카
히데오 사츠
쥰 가네코
요시노리 가타쿠라
미카코 사토
다카시 마츠모토
후미키 모리마츠
에츠코 이마바야시
히로시 마츠다
Original Assignee
고쿠리츠다이가쿠호우진 도쿄다이가쿠
고쿠리쯔겡뀨가이하쯔호징 고꾸리쯔 세이신ㆍ신께이 이료겡뀨센따
고쿠리쓰다이가쿠호진 규슈다이가쿠
닛뽄하무가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고쿠리츠다이가쿠호우진 도쿄다이가쿠, 고쿠리쯔겡뀨가이하쯔호징 고꾸리쯔 세이신ㆍ신께이 이료겡뀨센따, 고쿠리쓰다이가쿠호진 규슈다이가쿠, 닛뽄하무가부시키가이샤 filed Critical 고쿠리츠다이가쿠호우진 도쿄다이가쿠
Priority to KR1020227041506A priority Critical patent/KR20220164079A/ko
Publication of KR20160146760A publication Critical patent/KR20160146760A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/13—Dipeptidases (3.4.13)
    • C12Y304/1302—Beta-Ala-His dipeptidase (3.4.13.20)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8103—Exopeptidase (E.C. 3.4.11-19) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
KR1020167030159A 2014-03-28 2015-03-04 이미다졸디펩티드를 포함하는 제제 Ceased KR20160146760A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020227041506A KR20220164079A (ko) 2014-03-28 2015-03-04 이미다졸디펩티드를 포함하는 제제

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JPJP-P-2014-069103 2014-03-28
JP2014069103 2014-03-28
JP2014142910A JP2015193582A (ja) 2014-03-28 2014-07-11 イミダゾールジペプチドを含む剤
JPJP-P-2014-142910 2014-07-11
PCT/JP2015/056412 WO2015146522A1 (ja) 2014-03-28 2015-03-04 イミダゾールジペプチドを含む剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020227041506A Division KR20220164079A (ko) 2014-03-28 2015-03-04 이미다졸디펩티드를 포함하는 제제

Publications (1)

Publication Number Publication Date
KR20160146760A true KR20160146760A (ko) 2016-12-21

Family

ID=54195052

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020167030159A Ceased KR20160146760A (ko) 2014-03-28 2015-03-04 이미다졸디펩티드를 포함하는 제제
KR1020227041506A Ceased KR20220164079A (ko) 2014-03-28 2015-03-04 이미다졸디펩티드를 포함하는 제제

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020227041506A Ceased KR20220164079A (ko) 2014-03-28 2015-03-04 이미다졸디펩티드를 포함하는 제제

Country Status (8)

Country Link
US (2) US20170165314A1 (enExample)
EP (1) EP3124034B1 (enExample)
JP (1) JP2015193582A (enExample)
KR (2) KR20160146760A (enExample)
CN (1) CN106413733A (enExample)
ES (1) ES2879329T3 (enExample)
SG (2) SG11201608027RA (enExample)
WO (1) WO2015146522A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230087856A (ko) * 2021-12-10 2023-06-19 교촌 에프 앤 비(주) 생체이용율과 이미다졸 펩타이드가 증가된 수용성 닭가슴살 가수분해물 및 그 제조방법

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6401028B2 (ja) * 2014-11-27 2018-10-03 Ｓｈｉｏｄａライフサイエンス株式会社 鯨筋肉抽出物からなる中長期記憶障害予防改善剤
JP6550357B2 (ja) * 2016-08-24 2019-07-24 日本ハム株式会社 イミダゾールジペプチドを含有する、グリア細胞における神経栄養因子等の遺伝子の発現誘導剤
JP7134607B2 (ja) * 2016-08-25 2022-09-12 大正製薬株式会社 錠剤
JP6510004B2 (ja) * 2016-11-15 2019-05-08 日本ハム株式会社 イミダゾールジペプチドを含有するエクソソーム調節剤、およびエクソソームを含有する神経細胞活性化剤
JP2018140958A (ja) * 2017-02-28 2018-09-13 国立大学法人 東京大学 ペリサイトの変成を抑制する剤
US11498048B2 (en) 2017-10-13 2022-11-15 W.M. Barr & Company, Inc. Composition containing urea for use in brine formation
JP7251036B2 (ja) * 2018-06-28 2023-04-04 ポーラ化成工業株式会社 皮膚老化改善剤のスクリーニング方法
JP7464945B2 (ja) * 2018-10-26 2024-04-10 国立大学法人 東京大学 抗酸化剤、抗糖化剤又は抗炎症剤
JP7321017B2 (ja) * 2019-07-17 2023-08-04 東海物産株式会社 機能性食品
CN115066273A (zh) * 2019-12-27 2022-09-16 三得利控股株式会社 包含环二肽、嘌呤核苷和/或氨基酸以及鸡提取物的组合物、其生产方法以及环二肽、嘌呤核苷和/或氨基酸及鸡提取物的用途
US20230024193A1 (en) * 2020-02-26 2023-01-26 The University Of Tokyo Transistor-type sensor
CA3218849A1 (en) * 2021-05-14 2022-11-17 University Of Rochester Variants of sirt6 for use in preventing and/or treating age-related diseases
WO2025104978A1 (ja) * 2023-11-13 2025-05-22 国立大学法人 東京大学 ネクロプトーシス制御剤

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000116987A (ja) 1998-10-15 2000-04-25 Sanyo Electric Co Ltd 洗剤溶かし装置およびこれを備えた洗濯機ならびに静止型溶解装置
JP2000201649A (ja) 1999-01-13 2000-07-25 Nippon Meat Packers Inc 皮膚代謝促進物及び機能性食品
WO2002076455A1 (fr) 2001-03-16 2002-10-03 Suntory Limited Agents de regulation autonome et poissons et aliments dietetiques
JP2007070316A (ja) 2005-09-09 2007-03-22 Nippon Meat Packers Inc 経口用組成物及び栄養補助食品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960010020A (ko) * 1994-09-09 1996-04-20 도리이 신이치로 조혈 기능 항진제
ATE332127T1 (de) * 1994-11-08 2006-07-15 Avicena Group Inc Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose
JP2003513039A (ja) * 1999-11-03 2003-04-08 ジュヴェノン インコーポレイテッド 良性の健忘症を治療する方法
KR20020044740A (ko) * 2000-12-06 2002-06-19 강경선 카노신을 유효성분으로 하는 세포예정사 관련 질환의 예방및 치료제
US6498498B1 (en) * 2001-06-27 2002-12-24 Intel Corporation Apparatus and method for applying reciprocity to frequency-domain noise analysis
WO2003013514A1 (en) * 2001-08-08 2003-02-20 Carn-Aware Llc Improving neurological functions
US20060257502A1 (en) * 2005-05-11 2006-11-16 Jiankang Liu A combination of mitochondrial nutrients for relieving stress, preventing and improving stress-related disorders
WO2007116987A1 (ja) * 2006-03-31 2007-10-18 Nippon Meat Packers, Inc. 学習機能向上効果及び抗不安効果を有する機能性食品及び薬剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000116987A (ja) 1998-10-15 2000-04-25 Sanyo Electric Co Ltd 洗剤溶かし装置およびこれを備えた洗濯機ならびに静止型溶解装置
JP2000201649A (ja) 1999-01-13 2000-07-25 Nippon Meat Packers Inc 皮膚代謝促進物及び機能性食品
WO2002076455A1 (fr) 2001-03-16 2002-10-03 Suntory Limited Agents de regulation autonome et poissons et aliments dietetiques
JP2007070316A (ja) 2005-09-09 2007-03-22 Nippon Meat Packers Inc 経口用組成物及び栄養補助食品

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230087856A (ko) * 2021-12-10 2023-06-19 교촌 에프 앤 비(주) 생체이용율과 이미다졸 펩타이드가 증가된 수용성 닭가슴살 가수분해물 및 그 제조방법

Also Published As

Publication number Publication date
WO2015146522A1 (ja) 2015-10-01
EP3124034A4 (en) 2018-03-21
SG11201608027RA (en) 2016-11-29
JP2015193582A (ja) 2015-11-05
CN106413733A (zh) 2017-02-15
US20170165314A1 (en) 2017-06-15
EP3124034A1 (en) 2017-02-01
KR20220164079A (ko) 2022-12-12
EP3124034B1 (en) 2021-04-21
ES2879329T3 (es) 2021-11-22
US20180140655A1 (en) 2018-05-24
SG10201808208PA (en) 2018-10-30

Similar Documents

Publication Publication Date Title
KR20160146760A (ko) 이미다졸디펩티드를 포함하는 제제
EP2315532B1 (en) Compositions and methods for treating disorders associated with overweight animals
Mizoguchi et al. Nutrigenomic studies of effects of Chlorella on subjects with high-risk factors for lifestyle-related disease
TW201326399A (zh) 用於預測對格拉替雷（ｇｌａｔｉｒａｍｅｒ）醋酸鹽之臨床反應之單核苷酸多型性之判定
EP4260908A1 (en) Composition for preventing or treating deterioration in brain function or maintaining or improving brain function
JP7836235B2 (ja) イミダゾールジペプチドを含む剤
BRPI0708488A2 (pt) combinação, composição, dispositivo, métodos para detectar a expressão diferencial de um ou mais genes, para medir o efeito de uma substáncia de teste sobre a expressão de um ou mais genes e um método para triar uma substáncia de teste,para formular um prognóstico, para manipular o genoma de um animal não humano ou a expressão do genoma de um animal, para modular a expressão de um ou mais genes diferencialmente expressados, para selecionar um animal para a inclusão em um ou mais grupos, e para produzir um anticorpo, substáncia, animal transgênico, sistema de computador, anticorpo isolado e purificado, kit, meio para comunicar informação, e, usos dos dados de polinucleotìdeo e dos dados prognosticadores
JP5990871B2 (ja) 疲労の判定方法
MX2010011445A (es) Polimorfismos de nucleotido sencillo (snp) y asociacion con resistencia a la induccion de tolerancia inmunitaria.
Gui-Yan et al. Associations between RAS gene polymorphisms, environmental factors and hypertension in Mongolian people
JP2011530308A (ja) 満腹感、脂質代謝及び脂肪利用に影響を及ぼすための組成物及び方法
Karlic et al. Vegetarian diet affects genes of oxidative metabolism and collagen synthesis
KR101975952B1 (ko) 면역세포 수용체 2b4(cd244)의 염증성 장질환 진단 및 치료제로서의 용도
JP2012205590A (ja) 遺伝子発現を用いた疲労の判定方法
US20250333446A1 (en) Dietary supplements, compositions, and uses thereof for increasing telomerase activity and extending telomere length
KR102668508B1 (ko) 고염식 환경에서의 뇌종양 진단용 조성물
CN113943795B (zh) 一种用于检测噪音相关性耳聋基因的探针组及其试剂盒
JP6966784B2 (ja) 老化を反映するミトコンドリアバイオマーカー
KR20250113682A (ko) 비만 관리를 위한 바이오마커 기반의 개인 맞춤 생활습관 제공 방법
Karayasheva et al. Association Study of the Role of GLUT2 Receptor in Dental Caries Susceptibility, Dietary Habits and Body Mass Index (BMI)
JP6749697B2 (ja) フコキサンチンを含有する抗糖化組成物
WO2021054373A1 (ja) テロメアを伸長するための組成物
WO2020157357A1 (es) Método para predecir o pronosticar el desarrollo de la artritis reumatoide
Alam Feel the Pressure: Effects of Mechanical Deformation on Collagen Direction and Proliferation
Liu et al. The Anti-Inflammatory Potential of Lonicera Japonica Extract in LPS-Induced Inflammatory Diseases Was Studied by Transcriptomics

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20161027

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20191114

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210924

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20220629

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210924

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

A107 Divisional application of patent
J201 Request for trial against refusal decision
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20221125

PJ0201 Trial against decision of rejection

Patent event date: 20221125

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20220629

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Appeal identifier: 2022101002174

Request date: 20221125

J301 Trial decision

Free format text: TRIAL NUMBER: 2022101002174; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20221125

Effective date: 20230720

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20230720

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20221125

Decision date: 20230720

Appeal identifier: 2022101002174